MedTrace Logo

The Effect of Soy Isoflavone Supplementation on Endothelial Function

NCT01463436 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2011-11-02

No results posted yet for this study

Summary

A randomized double blind controlled trial was conducted to evaluate the effect of daily supplementation with soy isoflavone 100 mg/day for 12 months on 182 postmenopausal women aged 47 to 60 years at subdistrict South Jakarta Indonesia. The study hypothesis was supplementation soy isoflavone 100 mg/day for 6 and 12 months can increase endothelial function.

Conditions

Interventions

DIETARY_SUPPLEMENT

soy isoflavone

100 mg soy isoflavone tablet containing genistein 55%, daidzein 39% and glycitein 6% and calcium carbonate 500 mg in the experimental group for 6 months and 12 months

DIETARY_SUPPLEMENT

control group

the control group receiving tablet contain calcium carbonate 500 mg/day for 6 months and 12 months

Sponsors & Collaborators

  • Trisakti University

    lead OTHER

Principal Investigators

  • Pusparini Sunarno, Doctor · Trisakti University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
47 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-03-31
Completion
2011-02-28

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01463436 on ClinicalTrials.gov